Prostate Cancer
Defining aggressive prostate cancer: a geospatial perspective.
August 16, 2023
Evaluating the Learning Curve for In-Office Freehand Cognitive Fusion Transperineal Prostate Biopsy.
August 16, 2023
Germline genetic variants associated with somatic TMPRSS2:ERG fusion status in prostate cancer: a genome-wide association study.
August 16, 2023
Management of patients with localized prostate cancer and biochemical recurrence in Spain: A medical survey.
August 15, 2023
Combining PARP Inhibitors and Androgen Receptor Signalling Inhibitors in Metastatic Prostate Cancer: A Quantitative Synthesis and Meta-analysis.
August 15, 2023
Standardized PSMA-PET Imaging of Advanced Prostate Cancer.
August 14, 2023
Impact of [177Lu]Lu-PSMA-617 Radioligand Therapy on Reference Organ Uptake Assessed by [68Ga]Ga-PSMA-11-PET/CT.
August 14, 2023
Improved Prostate-Specific Membrane Antigen (PSMA) Stimulation Using a Super Additive Effect of Dutasteride and Lovastatin In Vitro.
August 14, 2023
A novel MRI/ultrasound fusion prostate biopsy technique using transperineal ultrasound: An initial experience.
August 14, 2023
Racial Disparities in Prostate Cancer Screening: The Role of Shared Decision-Making.
August 14, 2023
Copy number architectures define treatment-mediated selection of lethal prostate cancer clones.
August 14, 2023
Severe hypercalcaemia in metastatic prostate cancer with biallelic BRCA2 mutations and lytic bone lesions.
August 14, 2023
Discrete-Choice Experiment to Understand the Preferences of Patients with Hormone-Sensitive Prostate Cancer in the USA, Canada, and the UK.
August 14, 2023
How to Report PSMA PET.
August 11, 2023